MIF and ganglioneuroma: Immunocytochemical and in situ hybridization studies have shown that MIF is produced by local resident glomerular cells [22], and that administration of a neutralizing anti-MIF antibody dramatically suppresses an immunologically induced disease model of rapidly progressive crescentic glomerulonephritis (GN) [61].